FDA Updates Potency Rules for Cell and Gene Therapies - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Updates Potency Rules for Cell and Gene Therapies

Replacing guidance from 2011, the FDA's updated framework emphasizes potency assurance throughout cell and gene therapy development and manufacturing

  • November 11, 2026

  • 3 min

Share

Original Source(s)

FDA Updates Potency Rules for Cell and Gene Therapies

  • November 11, 2026

Related Content

From Evidence to Practice in Low-Risk Thyroid Cancer

Erin Gillaspie, M.D. M.P.H., Joins Baptist Health Herbert Wertheim Cancer Institute as Chief of Thoracic Surgery

Erin Gillaspie, M.D., M.P.H., has joined Baptist Health Herbert Wertheim Cancer Institute and Baptist Health Cancer Care as chief of thoracic surgery.

  • by

  • November 3, 2026

  • 3 min
Organ Preservation in Rectal Adenocarcinoma—A Growing Practice With Promise and Pitfalls